Join academic KOLs for a discussion on things yet to come for induced proximity therapeutics. Expect to cover next-generation PROTACs, degrader

antibody conjugates, the new focus on cooperative molecular glues, and non-degrading proximity therapeutics. This will be a chance to hear about the latest academic research, opportunities for growth in biopharma, and first-hand opinions from leading pioneers on where the TPD and induced proximity community is headed.